You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

enzalutamide

Showing 26 - 50 of 183
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Cancer, Tumor, Prostate Trial in Bronx (Abiraterone acetate, Apalutamide, Enzalutamide)

Not yet recruiting
  • Metastatic Cancer
  • Neoplasm, Prostate
  • Abiraterone acetate
  • +2 more
  • Bronx, New York
    James J. Peters VA Medical Center
Jun 16, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues

Active, not recruiting
Has Results
  • Castration-Resistant Prostate Carcinoma
  • +6 more
  • Enzalutamide
  • San Francisco, California
  • +1 more
Sep 20, 2022

Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in San Francisco (FOR46, Enzalutamide, Pegfilgrastim)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Prostate Cancer
  • FOR46
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Jun 1, 2022

Prostate Adenocarcinoma, Prostate Cancer, High Risk Prostate Cancer Trial in Baltimore, Boston, Seattle (Enzalutamide,

Completed
Has Results
  • Prostate Adenocarcinoma
  • +2 more
  • Enzalutamide
  • +3 more
  • Baltimore, Maryland
  • +3 more
Mar 30, 2022

Prostatic Tumors, Castration-Resistant Trial in Leiden (Patient-specific adaptive therapy, Abiraterone acetate, Enzalutamide)

Recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • Patient-specific adaptive therapy
  • +2 more
  • Camperdown, New South Wales, Australia
  • +6 more
Jan 11, 2023

Prostate Cancer Trial in Washington, Chicago, Baltimore (Enzalutamide, LY2157299)

Recruiting
  • Prostate Cancer
  • Washington, District of Columbia
  • +3 more
Jun 1, 2022

Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Scottsdale, Jacksonville, Rochester

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • Stage IVB Prostate Cancer AJCC v8
  • Biopsy
  • +7 more
  • Scottsdale, Arizona
  • +2 more
Feb 15, 2023

Prostate Cancer Trial in Japan (Enzalutamide)

Completed
  • Prostate Cancer
  • Enzalutamide
  • Kita-gun, Kagawa-prefecture, Japan
  • +3 more
May 24, 2022

Prostate Cancer, Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Baltimore

Recruiting
  • Prostate Cancer
  • +2 more
  • Testosterone Undecanoate
  • Enzalutamide
  • Baltimore, Maryland
    Johns Hopkins Hospital
May 6, 2022

Advanced Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in Houston

Recruiting
  • Advanced Breast Carcinoma
  • +17 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Prostate Cancer Metastatic Trial in Leiden (Enzalutamide, 18-FDG PET/CT, Whole body MRI)

Completed
  • Prostate Cancer Metastatic
  • Enzalutamide
  • +3 more
  • Leiden, Netherlands
    Leiden University Medical Center
Apr 6, 2022

Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer Trial in Sacramento (Enzalutamide,

Active, not recruiting
  • Metastatic Prostate Carcinoma
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Feb 23, 2022

Prostate Cancer Metastatic Trial in Leiden (Enzalutamide, 11C or 18F-Choline PET/CT, Whole body MRI)

Completed
  • Prostate Cancer Metastatic
  • Enzalutamide
  • +3 more
  • Leiden, Netherlands
    Leiden University Medical Center
Apr 6, 2022

Prostate Cancer Trial in Chisinau (enzalutamide, enzalutamide Placebo, digoxin)

Completed
  • Prostate Cancer
  • enzalutamide
  • +3 more
  • Chisinau, Moldova, Republic of
    Site MD37301
Jan 14, 2022

Prostatic Cancer, Castration-Resistant Trial in United States (Darolutamide(Nubeqa, BAY1841788), Enzalutamide)

Completed
  • Prostatic Cancer, Castration-Resistant
  • Darolutamide(Nubeqa, BAY1841788)
  • Enzalutamide
  • Portland, Maine
  • +6 more
Aug 18, 2022

Metastatic Castration-Resistant Prostate Cancer Trial in China, United States (ZEN003694, Enzalutamide)

Recruiting
  • Metastatic Castration-Resistant Prostate Cancer
  • San Francisco, California
  • +21 more
Aug 18, 2022

Metastatic Prostate Cancer, Prostate Cancer Metastatic, Prostate Cancer Trial in United States (Darolutamide, Enzalutamide)

Recruiting
  • Metastatic Prostate Cancer
  • +3 more
  • San Diego, California
  • +11 more
Nov 28, 2022

Prostate Cancer, Bone Metastases Trial in Brescia (Zoledronic Acid, Enzalutamide)

Recruiting
  • Prostate Cancer
  • Bone Metastases
  • Zoledronic Acid
  • Enzalutamide
  • Brescia, Italy
    Azienda Ospedaliera Spedali Civili di Brescia
Mar 4, 2022

Castration-resistant Prostate Cancer Trial in Boston (Crizotinib, Enzalutamide)

Completed
  • Castration-resistant Prostate Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 5, 2022

Prostate Cancer, Castration Resistant Prostate Cancer Trial in United States (Enzalutamide, CC-115)

Active, not recruiting
  • Prostate Cancer
  • Castration Resistant Prostate Cancer
  • San Francisco, California
  • +4 more
Mar 18, 2022

Breast Cancer Trial in Aurora, New York, Germantown (Enzalutamide, Fulvestrant)

Active, not recruiting
  • Breast Cancer
  • Aurora, Colorado
  • +2 more
Feb 22, 2022

Prostate Cancer, Prostatic Cancer, Cancer of Prostate Trial (NUV-422, Enzalutamide)

Not yet recruiting
  • Prostate Cancer
  • +7 more
  • (no location specified)
Jan 12, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in Portland, Seattle

Active, not recruiting
Has Results
  • Castration-Resistant Prostate Carcinoma
  • +3 more
  • Portland, Oregon
  • +2 more
Jun 24, 2022

Castration-Resistant Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8 Trial in Buffalo

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +3 more
  • Decitabine and Cedazuridine
  • Enzalutamide
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 27, 2022

Prostate Cancer Trial in Boston (Tivozanib, Enzalutamide)

Active, not recruiting
  • Prostate Cancer
  • Boston, Massachusetts
    Massachusetts General Hospital
Oct 25, 2021